0001179110-14-014045.txt : 20140910
0001179110-14-014045.hdr.sgml : 20140910
20140910160611
ACCESSION NUMBER: 0001179110-14-014045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140908
FILED AS OF DATE: 20140910
DATE AS OF CHANGE: 20140910
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILLIGAN JOHN F
CENTRAL INDEX KEY: 0001191589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 141095963
MAIL ADDRESS:
STREET 1: C/O GILEAD SCIENCES, INC.
STREET 2: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
edgar.xml
FORM 4 -
X0306
4
2014-09-08
0
0000882095
GILEAD SCIENCES INC
GILD
0001191589
MILLIGAN JOHN F
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
0
1
0
0
President and COO
Common Stock
2014-09-08
4
M
0
146895
8.005
A
1120943
D
Common Stock
2014-09-08
4
S
0
62389
105.6736
D
1058554
D
Common Stock
2014-09-08
4
S
0
84506
106.2267
D
974048
D
Non-Qualified Stock Option (right to buy)
8.005
2014-09-08
4
M
0
146895
0
D
2015-01-26
Common Stock
146895
440613
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
Sale prices reported for the transactions reported here range from $104.96 to $105.96. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $105.97 to $106.85. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
/s/ John F. Milligan
2014-09-10